Integrating Proteomics and Lipidomics for Evaluating the Risk of Breast Cancer Progression: A Pilot Study

Integrating Proteomics and Lipidomics for Evaluating the Risk of Breast Cancer Progression: A Pilot Study

Metastasis is a serious and often life-threatening condition, representing the leading cause of death among women with breast cancer (BC). Although the current clinical classification of BC is well-established, the addition of minimally invasive laboratory tests based on peripheral blood biomarkers...

Full description

Bibliographic Details
Main Authors: Natalia L. Starodubtseva, Alisa O. Tokareva, Valeriy V. Rodionov, Alexander G. Brzhozovskiy, Anna E. Bugrova, Vitaliy V. Chagovets, Vlada V. Kometova, Evgenii N. Kukaev, Nelson C. Soares, Grigoriy I. Kovalev, Alexey S. Kononikhin, Vladimir E. Frankevich, Evgeny N. Nikolaev, Gennady T. Sukhikh
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Biomedicines
Subjects:
breast cancer
metastasis
proteomics
lipidomics
mass spectrometry
serum
Online Access:https://www.mdpi.com/2227-9059/11/7/1786

Internet

https://www.mdpi.com/2227-9059/11/7/1786

Similar Items